Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05385705
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2022-05-17
Brief Title:
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer NK-ACT-BC_2020
Sponsor:
Vall dHebron Institute of Oncology
Organization:
Vall dHebron Institute of Oncology
Organization Data
Organization:
Vall dHebron Institute of Oncology
Class:
OTHER
Study ID:
VHIO20002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vall dHebron Institute of Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Banc de Sang i Teixits | OTHER |
| Clinica Universidad de Navarra Universidad de Navarra | OTHER |
| Puerta de Hierro University Hospital | OTHER |
| Hospital del Mar | OTHER |